Table 3. Haematological toxicities as occurred among 25 treated patients by the seven dose levels of gemcitabine tested.

Gemcitabine dose	Number of patients treated	Neutropenia (number of patients)			Thrombocytopenia (number of patients)
		Grade 2	Grade 3	Grade 4	Grade 2	Grade 3	Grade 4
25 mg m−2 weekly	4	1	0	0	1	0	0
25 mg m−2 twice weekly	3	0	0	0	0	0	0
37.5 mg m−2 twice weekly	3	0	0	0	0	0	0
50 mg m−2 twice weekly	7	0	0	0	3	0	0
62.5 mg m−2 twice weekly	6	0	0	1	1	1	1
75 mg m−2 twice weekly	2	0	0	1	0	1	0